SCHEMBL23748666

SCHEMBL23748666

CCCCCOc1cccc(C(=O)O)c1C(F)(F)F

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
NR1I2 O75469 1/20 0.52
LMNA P02545 1/20 0.52
CHRM2 P08172 1/20 0.52
CYP3A4 P08684 1/20 0.52
ADRA2A P08913 1/20 0.52
MAPT P10636 1/20 0.52
OPRK1 P41145 1/20 0.52
HTR2B P41595 1/20 0.52
SLC6A3 Q01959 1/20 0.52
HDAC6 Q9UBN7 1/20 0.52
PTPN11 Q06124 5/20 0.50
PTPN1 P18031 2/20 0.49
NPSR1 Q6W5P4 1/20 0.48
PLA2G2D Q9UNK4 1/20 0.46
S1PR3 Q99500 1/20 0.46
KDM4E B2RXH2 1/20 0.46
RECQL P46063 1/20 0.46
CYP2C9 P11712 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23748726 0.86 TSHR (0.60) MEN1KMT2ANR1I2LMNACHRM2
SCHEMBL30806950 0.82 ALDH1A1 (0.51) KMT2ALMNAKDM4E
SCHEMBL29391931 0.81 LMNA (0.71) MEN1KMT2ANR1I2LMNACHRM2
SCHEMBL301124 0.81 LMNA (0.71) MEN1KMT2ANR1I2LMNACHRM2
SCHEMBL8085939 0.80 MEN1 (0.57) MEN1KMT2ANR1I2LMNACHRM2
Orziloben SCHEMBL6531935 0.80 MEN1 (0.57) MEN1KMT2ANR1I2LMNACHRM2
SCHEMBL8080660 0.80 MEN1 (0.57) MEN1KMT2ANR1I2LMNACHRM2
SCHEMBL3665313 0.79 KMT2A (0.74) MEN1KMT2ANR1I2LMNACHRM2
SCHEMBL1274781 0.79 KMT2A (0.74) MEN1KMT2ANR1I2LMNACHRM2
SCHEMBL168816 0.79 KMT2A (0.74) MEN1KMT2ANR1I2LMNACHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12473249-B2 Aromatic compounds and pharmaceutical uses thereof BASF AS (NO) 2025-11-18 US disclosed
US-20210380521-A1 AROMATIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF BASF AS (NO) 2021-12-09 US disclosed
US-20210380521-A1 AROMATIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF BASF AS (NO) 2021-12-09 US disclosed
EP-3864001-A1 ROMATIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF BASF AS (NO) 2021-08-18 EP disclosed
CN-113166024-A Aromatic compounds and their medical use 巴斯夫股份公司 2021-07-23 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12473249-B2 Aromatic compounds and pharmaceutical uses thereof GLS2, FFAR3, SLC10A1 MEN1 2226/4885KMT2A 2026/4885NR1I2 282/4885
US-20210380521-A1 AROMATIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF GLS2, FFAR3, SLC10A1 MEN1 2226/4885KMT2A 2026/4885NR1I2 282/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.